A. Types
- Porcine - average lifespan ~8-10 years
- Metal - may have unlimited lifespan
- Caged-ball (Starr-Edwards)
- Single-tilting disk (Bjork-Shiley, Medtronic, Omnicarbon)
- Bileaflet-tilting disk (St. Jude Medical, Carbomedics, Edwards-Duromedics)
- Valve reconstruction can be performed in some cases
- Majority of valve replacements require open surgery
- Percutaneous placement of a pulmonary valve has been achieved [9]
B. Indications and Efficacy [1]
- Valve Disease
- Stenotic lesions tend to be more poorly tolerated than regurgitant lesions
- Valve replacement usually undertaken for symptomatic valve disease
- Timing of Valve Replacement
- Usually based on symptoms that limit patient's lifestyle
- Angina, dyspnea, syncope, congestive heart failure
- Ventricular dilation (even without symptoms) may be an indication
- Endocarditis, especially fungal or with abscess formation
- Advanced ventricular arrhythmias
- Efficacy
- Porcine valves last an average of 8-10 years
- Metal valves usually last 20-30 years
C. Risks Associated with Valve Replacement
- Endocarditis
- Stroke (usually with metal valves) [8]
- Valve Dehiscence
- Valve is sewed in surgically
- Valve can dehisce, or come apart, usually at suture sites
- Incidence of dehiscence is decreasing
- When it occurs acutely, acute pulmonary edema ensues (congestive heart failure)
- Acute pulmonary edema due to valve dehiscence is an emergency requiring re-operation
- Atrial Fibrillation [6]
- About half of patients undergoing valve replacement develop atrial fibrillation
- May be related to valvular disease type
- Pericardial trauma during surgery may predispose to arrhythmias
- Emergent electrical cardioversion may be required
- Surgical / Peri-Operative Mortality
- 2-15% depending on patient and number of valve replacements
- Comorbidities play major role in surgical risk
- Valve replacement + bypass grafting carries higher mortality risk
D. Evaluation of Valve Function [1]
- History of increasing cardiopulmonary symptoms is concerning for valve dysfunction
- Physical Examination - metal valve sounds are loud (changes in sound are concerning) [5]
- Transesophageal echocardiography may be preferred for evaluation of synthetic valve [2]
- MRI can be performed in most patients but is usually not helpful for metal valve function
E. Anti-Coagulation Therapy [5,7]
- Required for metal valves and initially (usually 3-6 months) for porcine valves
- Patients should be stratified by low or high risk based on comorbidities
- Many patients have atrial fibrillation
- Combination of oral anticoagulants with antiplatelet agents reduce thromboembolism and overall mortality in patients with mechanical heart valves [10]
- Embolic Stroke or Systemic Embolism
- Overall risk ~1-2% / year on warfarin (INR ~2.5-3.5)
- Risk is greatet in first year after heart valve
- Increased risk when variability in anticoagulation levels is highest [8]
- 15-75% of patients are adequately anticoagulated, depending on definition [8]
- Risk of ischemic stroke was <1% / year on warfarin INR 2.5-4 in Dutch Study [3]
- INR <4 asssociated with very low hemorrhagic stroke risk (<0.5% / year)
- Recommendation in that study was for target INR of 3.0-4.0
- Aspirin (100mg/day) + Warfarin [7,10]
- Anti-platelet therapy alone provides ~50% reduction in thromboembolic risk
- Lowers risk of embolic stroke to ~0.5% per year when combined with warfarin
- Increases risk of bleeding 1.5 fold
- Bleeding was mostly low grade GI bleeding, easily controlled
- Benefits of ASA added to warfarin clearly outweighed risks
- Dipyridamole also improves outcomes and mortality when added to warfarin [10]
References
- Carabello BA and Crawford FA Jr. 1997. NEJM. 337(1):32

- Daniel WG and Mugge A. 1995. NEJM. 332(19):1268

- Cannegieter SC, Rosendaal FR, Wintzen AR, et al. 1995. NEJM. 333(1):11

- Katz NM. 1995. Am Fam Phys. 52(2):559

- Vongpatanasin W, Hillis LD, Lange RA. 1996. NEJM. 335(6):407

- Ommen SR, Odell JA, Stanton MS. 1997. NEJM. 336(20):1429

- Turpie AG, Gent M, Laupacis A, et al. 1993. NEJM. 329(8):524

- Huber KC, Gersh BJ, Bailey KR, et al. 1997. Mayo Clin Proc. 72(12):1103

- Bonhoeffer P, Boudjemline Y, Saliba Z, et al. 2000. Lancet. 356(9239):1403

- Massel D and Little SH. 2001. J Am Coll Cardiol. 37:569
